FDA9h ago
Troubling Findings in Study of GLP-1 Compounders
A recent secret shopper study highlights persistent safety concerns within the market for compounded weight-loss drugs. Despite the formal resolution of shortages for semaglutide and tirzepatide in early 2025, weight-los…